1 study found for:    TH3RESA
Show Display Options
Rank Status Study
1 Active, not recruiting A Study of Trastuzumab Emtansine in Comparison With Treatment of Physician's Choice in Patients With HER2-Positive Breast Cancer Who Have Received at Least Two Prior Regimens of HER2-Directed Therapy (TH3RESA)
Condition: Breast Cancer
Interventions: Drug: trastuzumab emtansine [Kadcyla];   Drug: anti-cancer therapy

Indicates status has not been verified in more than two years